Panu Miettinen appointed Chief Financial Officer of Biotie
Panu Miettinen, 43, has been appointed Chief Financial Officer (CFO) of Biotie Therapies Corp., effective March 15, 2012. He will become a member of the Group's management team and will report to Timo Veromaa, President and Chief Executive Officer. Panu Miettinen will be based at the Company's headquarters in Turku, Finland. Zack McNealy, current interim CFO, will resume his prior duties as Vice President, Finance and Administration at the Group's U.S. subsidiary.
Panu Miettinen, a Finnish native, has extensive expertise in finance, strategy, investor relations, and M&A. Previously Panu was the CFO of Elektrobit Corporation, a NASDAQ OMX Helsinki Ltd. listed company. Before joining Elektrobit Panu was a Management Consultant at Accenture and KPMG Consulting. Panu holds a M.Sc. (Economics) degree from Helsinki School of Economics, Finland.
Other news from the department people

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.